Matches in Wikidata for { <http://www.wikidata.org/entity/Q63815448> ?p ?o ?g. }
Showing items 1 to 35 of
35
with 100 items per page.
- Q63815448 description "clinical trial" @default.
- Q63815448 description "ensayu clínicu" @default.
- Q63815448 description "klinisch onderzoek" @default.
- Q63815448 description "клінічне випробування" @default.
- Q63815448 description "կլինիկական փորձարկում" @default.
- Q63815448 name "A Study to Determine Acute (After First Dose) and Chronic (After 28 Days) Effects of Empagliflozin (BI 10773) on Pre and Postprandial Glucose Homeostasis in Patients With Impaired Glucose Tolerance and Type 2 Diabetes Mellitus and Healthy Subjec" @default.
- Q63815448 type Item @default.
- Q63815448 label "A Study to Determine Acute (After First Dose) and Chronic (After 28 Days) Effects of Empagliflozin (BI 10773) on Pre and Postprandial Glucose Homeostasis in Patients With Impaired Glucose Tolerance and Type 2 Diabetes Mellitus and Healthy Subjec" @default.
- Q63815448 prefLabel "A Study to Determine Acute (After First Dose) and Chronic (After 28 Days) Effects of Empagliflozin (BI 10773) on Pre and Postprandial Glucose Homeostasis in Patients With Impaired Glucose Tolerance and Type 2 Diabetes Mellitus and Healthy Subjec" @default.
- Q63815448 P1050 Q63815448-FCF00D1B-E5AF-4129-A31C-02E9F954FC7A @default.
- Q63815448 P1132 Q63815448-BA9B396B-DEBC-418F-AF4A-C0C25F687EB7 @default.
- Q63815448 P1476 Q63815448-E3E9D9D0-C949-4F20-986A-CE9A12649945 @default.
- Q63815448 P17 Q63815448-398D6945-9FD1-4487-ABB6-F6AE1AC1C969 @default.
- Q63815448 P17 Q63815448-7302CC91-8F94-40DC-9D69-1036BF745B16 @default.
- Q63815448 P17 Q63815448-F04C3C36-10EC-4DB7-B59D-4CE85B90A802 @default.
- Q63815448 P2899 Q63815448-66CAF427-3486-4EE9-AC7B-2B6F949B97D9 @default.
- Q63815448 P3098 Q63815448-D4718DA7-39EF-448C-BBD8-D403DE68F5A2 @default.
- Q63815448 P31 Q63815448-5A6443E7-5E8E-43C3-AFB3-1EA5804D18EF @default.
- Q63815448 P580 Q63815448-935D4F69-517E-40CC-BBBA-BEC316C81F9C @default.
- Q63815448 P582 Q63815448-38C2951D-7BB0-4FC1-8575-A14466513063 @default.
- Q63815448 P6099 Q63815448-941F281B-3777-47FF-BCBB-F35A1205F1F5 @default.
- Q63815448 P8363 Q63815448-61E55005-2542-4D0D-9D8D-CD42AFE10F9C @default.
- Q63815448 P1050 Q12206 @default.
- Q63815448 P1132 "+91" @default.
- Q63815448 P1476 "An Open-label, Phase II Study to Determine Acute (After the First Dose Administration) and Chronic (After 28 Days of Treatment) Effects of the Sodium-glucose Co-transporter-2 (SGLT-2) Inhibitor Empagliflozin (BI 10773) (25 mg Once Daily) on Pre and Postprandial Glucose Homeostasis in Patients With IGT and, Type 2 Diabetes Mellitus and Healthy Subjects" @default.
- Q63815448 P17 Q183 @default.
- Q63815448 P17 Q38 @default.
- Q63815448 P17 Q40 @default.
- Q63815448 P2899 "+18" @default.
- Q63815448 P3098 "NCT01248364" @default.
- Q63815448 P31 Q30612 @default.
- Q63815448 P580 "2010-11-01T00:00:00Z" @default.
- Q63815448 P582 "2013-07-01T00:00:00Z" @default.
- Q63815448 P6099 Q42824440 @default.
- Q63815448 P8363 Q78089383 @default.